A method for regioselective N-alkylation of ambident,
azole-type heterocycles with alkene or epoxide electrophiles is described.
In the presence of diphenylborinic acid (Ph2BOH) and an
amine cocatalyst, heterocyclic nucleophiles such as 1,2,3- and 1,2,4-triazoles,
substituted tetrazoles, and purine are activated toward selective N-functionalization. The scope of electrophilic partners
includes enones, 2-vinylpyridine, phenyl vinyl sulfone, a dehydroalanine
derivative, and epoxides. Mechanistic studies, including in situ 11B NMR spectroscopy and kinetic analysis, are discussed.
A method for regioselective palladium-catalyzed allylic alkylation of ambident nitrogen heterocycles, employing simple allylic alcohols as electrophile precursors, is described. An organoboron co-catalyst serves both to activate the azole-type nucleophile toward selective N-functionalization and to accelerate the formation of a π-allylpalladium complex from the allylic alcohol. The method can be applied to various heterocycle types, including 1,2,3-and 1,2,4-triazoles, tetrazoles, pyrazoles, and purines, and can be extended to substituted allylic alcohol partners.
A dearomative electrophilic fluorination
of 2-methylindoles is
reported, delivering 3,3-difluoroindolines bearing an exomethylidene.
The model substrate was synthesized on up to a 20 mmol scale and was
purified by a practical recrystallization as a crystalline bench-stable,
yet reactive solid. The olefin is amphoteric and can react both as
a nucleophile and as an electrophile. A wide range of metal-free,
palladium, rhodium, and copper reactions was explored, forming new
C–H, C–B, C–C (alkyl and aryl), C–N, C–O,
C–P, and C–S bonds.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.